P1373: TACKLING IMMUNOLOGICAL FINDINGS AS SURROGATE MARKERS OF HISTOLOGICAL SEVERITY AND RESPONSE TO THERAPY IN ACUTE GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE

Gelijkaardige items

• P1373: TACKLING IMMUNOLOGICAL FINDINGS AS SURROGATE MARKERS OF HISTOLOGICAL SEVERITY AND RESPONSE TO THERAPY IN ACUTE GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE
  door: M. Sousa-Pimenta, et al.
  Gepubliceerd in: (2022-06-01)
• PB2177: ANTITHYMOCYTE GLOBULIN AS TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE - 10 YEARS OF EXPERIENCE AT A SINGLE-CENTER
  door: C. Dantas Rodrigues, et al.
  Gepubliceerd in: (2022-06-01)
• P1372: REAL-WORLD RETROSPECTIVE ANALYSIS OF INFECTIOUS COMPLICATIONS AFTER RUXOLITNIB USE IN ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE
  door: C. Sol Reis, et al.
  Gepubliceerd in: (2022-06-01)
• Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated
  door: Sarah Nikiforow, et al.
  Gepubliceerd in: (2018-10-01)
• Diffuse Sloughing of Gastrointestinal Mucosa in Acute Upper Gastrointestinal Graft-Versus-Host Disease
  door: Yasutoshi Shiratori, et al.
  Gepubliceerd in: (2023-01-01)